Ligand Determinants of Drug Trapping in hERG Potassium Channels
Excerpt
Inhibition of hERG channels prolongs the ventricular action potential and correspondingly the QT-interval with the risk of torsade de pointes arrhythmias which may result in sudden cardiac death.[...]
Share and Cite
WINDISCH, A.; SCHIESARO, A.; THAI, K.-M.; TIMIN, E.; HOHAUS, A.; ECKER, G.F.; HERING, S. Ligand Determinants of Drug Trapping in hERG Potassium Channels. Sci. Pharm. 2009, 77, 226. https://doi.org/10.3797/scipharm.oephg.21.PO-27
WINDISCH A, SCHIESARO A, THAI K-M, TIMIN E, HOHAUS A, ECKER GF, HERING S. Ligand Determinants of Drug Trapping in hERG Potassium Channels. Scientia Pharmaceutica. 2009; 77(Posters (PO)):226. https://doi.org/10.3797/scipharm.oephg.21.PO-27
Chicago/Turabian StyleWINDISCH, A., A. SCHIESARO, K.-M. THAI, E. TIMIN, A. HOHAUS, G. F. ECKER, and S. HERING. 2009. "Ligand Determinants of Drug Trapping in hERG Potassium Channels" Scientia Pharmaceutica 77, Posters (PO): 226. https://doi.org/10.3797/scipharm.oephg.21.PO-27
APA StyleWINDISCH, A., SCHIESARO, A., THAI, K. -M., TIMIN, E., HOHAUS, A., ECKER, G. F., & HERING, S. (2009). Ligand Determinants of Drug Trapping in hERG Potassium Channels. Scientia Pharmaceutica, 77(Posters (PO)), 226. https://doi.org/10.3797/scipharm.oephg.21.PO-27